Who are the key players in the urology drugs market?

Some of the key players are Astellas, Endo, GP Pharm, Tolmar, Others.

Global Urology Drugs Market Insights and Forecast to 2028

Q: How big is the urology drugs market?

Market Analysis and Insights Global Urology Drugs MarketDue to the COVID19 pandemic the global Urology Drugs market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

Code: QYRE-Auto-6T8081

Report

January 2022

72 Pages

QYResearch

Region: China, Global,

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Astellas

Endo

GP Pharm

Tolmar

Market Analysis and Insights: Global Urology Drugs Market

Due to the COVID-19 pandemic, the global Urology Drugs market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, Α (alpha) Blockers accounting for % of the Urology Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospital segment is altered to an % CAGR throughout this forecast period.

China Urology Drugs market size is valued at US$ million in 2021, while the US and Europe Urology Drugs are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Urology Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Urology Drugs include Astellas, Endo, GP Pharm and Tolmar, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Global Urology Drugs Scope and Segment

Urology Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Urology Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Α (alpha) Blockers

5 α-reductase Inhibitors

Segment by Application

Hospital

Clinic

Others

BY COMPANY

Astellas

Endo

GP Pharm

Tolmar

BY REGION

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

FEATURED COMPANIES

Astellas

Endo

GP Pharm

Tolmar

1 Study Coverage

1.1 Urology Drugs Product Introduction

1.2 Market by Type

1.2.1 Global Urology Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Α (alpha) Blockers

1.2.3 5 α-reductase Inhibitors

1.3 Market by Application

1.3.1 Global Urology Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Urology Drugs Sales Estimates and Forecasts 2017-2028

2.2 Global Urology Drugs Revenue Estimates and Forecasts 2017-2028

2.3 Global Urology Drugs Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Urology Drugs Sales by Region

2.4.1 Global Urology Drugs Sales by Region (2017-2022)

2.4.2 Global Sales Urology Drugs by Region (2023-2028)

2.5 Global Urology Drugs Revenue by Region

2.5.1 Global Urology Drugs Revenue by Region (2017-2022)

2.5.2 Global Urology Drugs Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Urology Drugs Sales by Manufacturers

3.1.1 Global Top Urology Drugs Manufacturers by Sales (2017-2022)

3.1.2 Global Urology Drugs Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Urology Drugs in 2021

3.2 Global Urology Drugs Revenue by Manufacturers

3.2.1 Global Urology Drugs Revenue by Manufacturers (2017-2022)

3.2.2 Global Urology Drugs Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Urology Drugs Revenue in 2021

3.3 Global Urology Drugs Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Urology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Urology Drugs Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Urology Drugs Sales by Type

4.1.1 Global Urology Drugs Historical Sales by Type (2017-2022)

4.1.2 Global Urology Drugs Forecasted Sales by Type (2023-2028)

4.1.3 Global Urology Drugs Sales Market Share by Type (2017-2028)

4.2 Global Urology Drugs Revenue by Type

4.2.1 Global Urology Drugs Historical Revenue by Type (2017-2022)

4.2.2 Global Urology Drugs Forecasted Revenue by Type (2023-2028)

4.2.3 Global Urology Drugs Revenue Market Share by Type (2017-2028)

4.3 Global Urology Drugs Price by Type

4.3.1 Global Urology Drugs Price by Type (2017-2022)

4.3.2 Global Urology Drugs Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Urology Drugs Sales by Application

5.1.1 Global Urology Drugs Historical Sales by Application (2017-2022)

5.1.2 Global Urology Drugs Forecasted Sales by Application (2023-2028)

5.1.3 Global Urology Drugs Sales Market Share by Application (2017-2028)

5.2 Global Urology Drugs Revenue by Application

5.2.1 Global Urology Drugs Historical Revenue by Application (2017-2022)

5.2.2 Global Urology Drugs Forecasted Revenue by Application (2023-2028)

5.2.3 Global Urology Drugs Revenue Market Share by Application (2017-2028)

5.3 Global Urology Drugs Price by Application

5.3.1 Global Urology Drugs Price by Application (2017-2022)

5.3.2 Global Urology Drugs Price Forecast by Application (2023-2028)

6 North America

6.1 North America Urology Drugs Market Size by Type

6.1.1 North America Urology Drugs Sales by Type (2017-2028)

6.1.2 North America Urology Drugs Revenue by Type (2017-2028)

6.2 North America Urology Drugs Market Size by Application

6.2.1 North America Urology Drugs Sales by Application (2017-2028)

6.2.2 North America Urology Drugs Revenue by Application (2017-2028)

6.3 North America Urology Drugs Market Size by Country

6.3.1 North America Urology Drugs Sales by Country (2017-2028)

6.3.2 North America Urology Drugs Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Urology Drugs Market Size by Type

7.1.1 Europe Urology Drugs Sales by Type (2017-2028)

7.1.2 Europe Urology Drugs Revenue by Type (2017-2028)

7.2 Europe Urology Drugs Market Size by Application

7.2.1 Europe Urology Drugs Sales by Application (2017-2028)

7.2.2 Europe Urology Drugs Revenue by Application (2017-2028)

7.3 Europe Urology Drugs Market Size by Country

7.3.1 Europe Urology Drugs Sales by Country (2017-2028)

7.3.2 Europe Urology Drugs Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Urology Drugs Market Size by Type

8.1.1 Asia Pacific Urology Drugs Sales by Type (2017-2028)

8.1.2 Asia Pacific Urology Drugs Revenue by Type (2017-2028)

8.2 Asia Pacific Urology Drugs Market Size by Application

8.2.1 Asia Pacific Urology Drugs Sales by Application (2017-2028)

8.2.2 Asia Pacific Urology Drugs Revenue by Application (2017-2028)

8.3 Asia Pacific Urology Drugs Market Size by Region

8.3.1 Asia Pacific Urology Drugs Sales by Region (2017-2028)

8.3.2 Asia Pacific Urology Drugs Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Urology Drugs Market Size by Type

9.1.1 Latin America Urology Drugs Sales by Type (2017-2028)

9.1.2 Latin America Urology Drugs Revenue by Type (2017-2028)

9.2 Latin America Urology Drugs Market Size by Application

9.2.1 Latin America Urology Drugs Sales by Application (2017-2028)

9.2.2 Latin America Urology Drugs Revenue by Application (2017-2028)

9.3 Latin America Urology Drugs Market Size by Country

9.3.1 Latin America Urology Drugs Sales by Country (2017-2028)

9.3.2 Latin America Urology Drugs Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Urology Drugs Market Size by Type

10.1.1 Middle East and Africa Urology Drugs Sales by Type (2017-2028)

10.1.2 Middle East and Africa Urology Drugs Revenue by Type (2017-2028)

10.2 Middle East and Africa Urology Drugs Market Size by Application

10.2.1 Middle East and Africa Urology Drugs Sales by Application (2017-2028)

10.2.2 Middle East and Africa Urology Drugs Revenue by Application (2017-2028)

10.3 Middle East and Africa Urology Drugs Market Size by Country

10.3.1 Middle East and Africa Urology Drugs Sales by Country (2017-2028)

10.3.2 Middle East and Africa Urology Drugs Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Astellas

11.1.1 Astellas Corporation Information

11.1.2 Astellas Overview

11.1.3 Astellas Urology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Astellas Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Astellas Recent Developments

11.2 Endo

11.2.1 Endo Corporation Information

11.2.2 Endo Overview

11.2.3 Endo Urology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Endo Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Endo Recent Developments

11.3 GP Pharm

11.3.1 GP Pharm Corporation Information

11.3.2 GP Pharm Overview

11.3.3 GP Pharm Urology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 GP Pharm Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 GP Pharm Recent Developments

11.4 Tolmar

11.4.1 Tolmar Corporation Information

11.4.2 Tolmar Overview

11.4.3 Tolmar Urology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Tolmar Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Tolmar Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Urology Drugs Industry Chain Analysis

12.2 Urology Drugs Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Urology Drugs Production Mode & Process

12.4 Urology Drugs Sales and Marketing

12.4.1 Urology Drugs Sales Channels

12.4.2 Urology Drugs Distributors

12.5 Urology Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Urology Drugs Industry Trends

13.2 Urology Drugs Market Drivers

13.3 Urology Drugs Market Challenges

13.4 Urology Drugs Market Restraints

14 Key Findings in The Global Urology Drugs Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Astellas

Endo

GP Pharm

Tolmar

List of Tables

Table 1. Global Urology Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of Α (alpha) Blockers

Table 3. Major Manufacturers of 5 α-reductase Inhibitors

Table 4. Global Urology Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

Table 5. Global Urology Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)

Table 6. Global Urology Drugs Sales by Region (2017-2022) & (MT)

Table 7. Global Urology Drugs Sales Market Share by Region (2017-2022)

Table 8. Global Urology Drugs Sales by Region (2023-2028) & (MT)

Table 9. Global Urology Drugs Sales Market Share by Region (2023-2028)

Table 10. Global Urology Drugs Revenue by Region (2017-2022) & (US$ Million)

Table 11. Global Urology Drugs Revenue Market Share by Region (2017-2022)

Table 12. Global Urology Drugs Revenue by Region (2023-2028) & (US$ Million)

Table 13. Global Urology Drugs Revenue Market Share by Region (2023-2028)

Table 14. Global Urology Drugs Sales by Manufacturers (2017-2022) & (MT)

Table 15. Global Urology Drugs Sales Share by Manufacturers (2017-2022)

Table 16. Global Urology Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 17. Global Urology Drugs Revenue Share by Manufacturers (2017-2022)

Table 18. Urology Drugs Price by Manufacturers (2017-2022) &(USD/Kg)

Table 19. Global Urology Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 20. Global Urology Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urology Drugs as of 2021)

Table 21. Urology Drugs Manufacturing Base Distribution and Headquarters

Table 22. Manufacturers Urology Drugs Product Offered

Table 23. Date of Manufacturers Enter into Urology Drugs Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Urology Drugs Sales by Type (2017-2022) & (MT)

Table 26. Global Urology Drugs Sales by Type (2023-2028) & (MT)

Table 27. Global Urology Drugs Sales Share by Type (2017-2022)

Table 28. Global Urology Drugs Sales Share by Type (2023-2028)

Table 29. Global Urology Drugs Revenue by Type (2017-2022) & (US$ Million)

Table 30. Global Urology Drugs Revenue by Type (2023-2028) & (US$ Million)

Table 31. Global Urology Drugs Revenue Share by Type (2017-2022)

Table 32. Global Urology Drugs Revenue Share by Type (2023-2028)

Table 33. Urology Drugs Price by Type (2017-2022) & (USD/Kg)

Table 34. Global Urology Drugs Price Forecast by Type (2023-2028) & (USD/Kg)

Table 35. Global Urology Drugs Sales by Application (2017-2022) & (MT)

Table 36. Global Urology Drugs Sales by Application (2023-2028) & (MT)

Table 37. Global Urology Drugs Sales Share by Application (2017-2022)

Table 38. Global Urology Drugs Sales Share by Application (2023-2028)

Table 39. Global Urology Drugs Revenue by Application (2017-2022) & (US$ Million)

Table 40. Global Urology Drugs Revenue by Application (2023-2028) & (US$ Million)

Table 41. Global Urology Drugs Revenue Share by Application (2017-2022)

Table 42. Global Urology Drugs Revenue Share by Application (2023-2028)

Table 43. Urology Drugs Price by Application (2017-2022) & (USD/Kg)

Table 44. Global Urology Drugs Price Forecast by Application (2023-2028) & (USD/Kg)

Table 45. North America Urology Drugs Sales by Type (2017-2022) & (MT)

Table 46. North America Urology Drugs Sales by Type (2023-2028) & (MT)

Table 47. North America Urology Drugs Revenue by Type (2017-2022) & (US$ Million)

Table 48. North America Urology Drugs Revenue by Type (2023-2028) & (US$ Million)

Table 49. North America Urology Drugs Sales by Application (2017-2022) & (MT)

Table 50. North America Urology Drugs Sales by Application (2023-2028) & (MT)

Table 51. North America Urology Drugs Revenue by Application (2017-2022) & (US$ Million)

Table 52. North America Urology Drugs Revenue by Application (2023-2028) & (US$ Million)

Table 53. North America Urology Drugs Sales by Country (2017-2022) & (MT)

Table 54. North America Urology Drugs Sales by Country (2023-2028) & (MT)

Table 55. North America Urology Drugs Revenue by Country (2017-2022) & (US$ Million)

Table 56. North America Urology Drugs Revenue by Country (2023-2028) & (US$ Million)

Table 57. Europe Urology Drugs Sales by Type (2017-2022) & (MT)

Table 58. Europe Urology Drugs Sales by Type (2023-2028) & (MT)

Table 59. Europe Urology Drugs Revenue by Type (2017-2022) & (US$ Million)

Table 60. Europe Urology Drugs Revenue by Type (2023-2028) & (US$ Million)

Table 61. Europe Urology Drugs Sales by Application (2017-2022) & (MT)

Table 62. Europe Urology Drugs Sales by Application (2023-2028) & (MT)

Table 63. Europe Urology Drugs Revenue by Application (2017-2022) & (US$ Million)

Table 64. Europe Urology Drugs Revenue by Application (2023-2028) & (US$ Million)

Table 65. Europe Urology Drugs Sales by Country (2017-2022) & (MT)

Table 66. Europe Urology Drugs Sales by Country (2023-2028) & (MT)

Table 67. Europe Urology Drugs Revenue by Country (2017-2022) & (US$ Million)

Table 68. Europe Urology Drugs Revenue by Country (2023-2028) & (US$ Million)

Table 69. Asia Pacific Urology Drugs Sales by Type (2017-2022) & (MT)

Table 70. Asia Pacific Urology Drugs Sales by Type (2023-2028) & (MT)

Table 71. Asia Pacific Urology Drugs Revenue by Type (2017-2022) & (US$ Million)

Table 72. Asia Pacific Urology Drugs Revenue by Type (2023-2028) & (US$ Million)

Table 73. Asia Pacific Urology Drugs Sales by Application (2017-2022) & (MT)

Table 74. Asia Pacific Urology Drugs Sales by Application (2023-2028) & (MT)

Table 75. Asia Pacific Urology Drugs Revenue by Application (2017-2022) & (US$ Million)

Table 76. Asia Pacific Urology Drugs Revenue by Application (2023-2028) & (US$ Million)

Table 77. Asia Pacific Urology Drugs Sales by Region (2017-2022) & (MT)

Table 78. Asia Pacific Urology Drugs Sales by Region (2023-2028) & (MT)

Table 79. Asia Pacific Urology Drugs Revenue by Region (2017-2022) & (US$ Million)

Table 80. Asia Pacific Urology Drugs Revenue by Region (2023-2028) & (US$ Million)

Table 81. Latin America Urology Drugs Sales by Type (2017-2022) & (MT)

Table 82. Latin America Urology Drugs Sales by Type (2023-2028) & (MT)

Table 83. Latin America Urology Drugs Revenue by Type (2017-2022) & (US$ Million)

Table 84. Latin America Urology Drugs Revenue by Type (2023-2028) & (US$ Million)

Table 85. Latin America Urology Drugs Sales by Application (2017-2022) & (MT)

Table 86. Latin America Urology Drugs Sales by Application (2023-2028) & (MT)

Table 87. Latin America Urology Drugs Revenue by Application (2017-2022) & (US$ Million)

Table 88. Latin America Urology Drugs Revenue by Application (2023-2028) & (US$ Million)

Table 89. Latin America Urology Drugs Sales by Country (2017-2022) & (MT)

Table 90. Latin America Urology Drugs Sales by Country (2023-2028) & (MT)

Table 91. Latin America Urology Drugs Revenue by Country (2017-2022) & (US$ Million)

Table 92. Latin America Urology Drugs Revenue by Country (2023-2028) & (US$ Million)

Table 93. Middle East and Africa Urology Drugs Sales by Type (2017-2022) & (MT)

Table 94. Middle East and Africa Urology Drugs Sales by Type (2023-2028) & (MT)

Table 95. Middle East and Africa Urology Drugs Revenue by Type (2017-2022) & (US$ Million)

Table 96. Middle East and Africa Urology Drugs Revenue by Type (2023-2028) & (US$ Million)

Table 97. Middle East and Africa Urology Drugs Sales by Application (2017-2022) & (MT)

Table 98. Middle East and Africa Urology Drugs Sales by Application (2023-2028) & (MT)

Table 99. Middle East and Africa Urology Drugs Revenue by Application (2017-2022) & (US$ Million)

Table 100. Middle East and Africa Urology Drugs Revenue by Application (2023-2028) & (US$ Million)

Table 101. Middle East and Africa Urology Drugs Sales by Country (2017-2022) & (MT)

Table 102. Middle East and Africa Urology Drugs Sales by Country (2023-2028) & (MT)

Table 103. Middle East and Africa Urology Drugs Revenue by Country (2017-2022) & (US$ Million)

Table 104. Middle East and Africa Urology Drugs Revenue by Country (2023-2028) & (US$ Million)

Table 105. Astellas Corporation Information

Table 106. Astellas Description and Major Businesses

Table 107. Astellas Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 108. Astellas Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 109. Astellas Recent Developments

Table 110. Endo Corporation Information

Table 111. Endo Description and Major Businesses

Table 112. Endo Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 113. Endo Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 114. Endo Recent Developments

Table 115. GP Pharm Corporation Information

Table 116. GP Pharm Description and Major Businesses

Table 117. GP Pharm Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 118. GP Pharm Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 119. GP Pharm Recent Developments

Table 120. Tolmar Corporation Information

Table 121. Tolmar Description and Major Businesses

Table 122. Tolmar Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)

Table 123. Tolmar Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 124. Tolmar Recent Developments

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Urology Drugs Distributors List

Table 128. Urology Drugs Customers List

Table 129. Urology Drugs Market Trends

Table 130. Urology Drugs Market Drivers

Table 131. Urology Drugs Market Challenges

Table 132. Urology Drugs Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Urology Drugs Product Picture

Figure 3. Global Urology Drugs Market Share by Type in 2021 & 2028

Figure 3. Α (alpha) Blockers Product Picture

Figure 4. 5 α-reductase Inhibitors Product Picture

Figure 5. Global Urology Drugs Market Share by Application in 2021 & 2028

Figure 6. Hospital

Figure 7. Clinic

Figure 8. Others

Figure 9. Urology Drugs Report Years Considered

Figure 10. Global Urology Drugs Sales 2017-2028 (MT)

Figure 11. Global Urology Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 12. Global Urology Drugs Revenue 2017-2028 (US$ Million)

Figure 13. Global Urology Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028

Figure 14. Global Urology Drugs Sales Market Share by Region (2017-2022)

Figure 15. Global Urology Drugs Sales Market Share by Region (2023-2028)

Figure 16. North America Urology Drugs Sales YoY (2017-2028) & (MT)

Figure 17. North America Urology Drugs Revenue YoY (2017-2028) & (US$ Million)

Figure 18. Europe Urology Drugs Sales YoY (2017-2028) & (MT)

Figure 19. Europe Urology Drugs Revenue YoY (2017-2028) & (US$ Million)

Figure 20. Asia-Pacific Urology Drugs Sales YoY (2017-2028) & (MT)

Figure 21. Asia-Pacific Urology Drugs Revenue YoY (2017-2028) & (US$ Million)

Figure 22. Latin America Urology Drugs Sales YoY (2017-2028) & (MT)

Figure 23. Latin America Urology Drugs Revenue YoY (2017-2028) & (US$ Million)

Figure 24. Middle East & Africa Urology Drugs Sales YoY (2017-2028) & (MT)

Figure 25. Middle East & Africa Urology Drugs Revenue YoY (2017-2028) & (US$ Million)

Figure 26. The Urology Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021

Figure 27. The Top 5 and 10 Largest Manufacturers of Urology Drugs in the World: Market Share by Urology Drugs Revenue in 2021

Figure 28. Global Urology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021

Figure 29. Global Urology Drugs Sales Market Share by Type (2017-2028)

Figure 30. Global Urology Drugs Revenue Market Share by Type (2017-2028)

Figure 31. Global Urology Drugs Sales Market Share by Application (2017-2028)

Figure 32. Global Urology Drugs Revenue Market Share by Application (2017-2028)

Figure 33. North America Urology Drugs Sales Market Share by Type (2017-2028)

Figure 34. North America Urology Drugs Revenue Market Share by Type (2017-2028)

Figure 35. North America Urology Drugs Sales Market Share by Application (2017-2028)

Figure 36. North America Urology Drugs Revenue Market Share by Application (2017-2028)

Figure 37. North America Urology Drugs Sales Share by Country (2017-2028)

Figure 38. North America Urology Drugs Revenue Share by Country (2017-2028)

Figure 39. U.S. Urology Drugs Revenue (2017-2028) & (US$ Million)

Figure 40. Canada Urology Drugs Revenue (2017-2028) & (US$ Million)

Figure 41. Europe Urology Drugs Sales Market Share by Type (2017-2028)

Figure 42. Europe Urology Drugs Revenue Market Share by Type (2017-2028)

Figure 43. Europe Urology Drugs Sales Market Share by Application (2017-2028)

Figure 44. Europe Urology Drugs Revenue Market Share by Application (2017-2028)

Figure 45. Europe Urology Drugs Sales Share by Country (2017-2028)

Figure 46. Europe Urology Drugs Revenue Share by Country (2017-2028)

Figure 47. Germany Urology Drugs Revenue (2017-2028) & (US$ Million)

Figure 48. France Urology Drugs Revenue (2017-2028) & (US$ Million)

Figure 49. U.K. Urology Drugs Revenue (2017-2028) & (US$ Million)

Figure 50. Italy Urology Drugs Revenue (2017-2028) & (US$ Million)

Figure 51. Russia Urology Drugs Revenue (2017-2028) & (US$ Million)

Figure 52. Asia Pacific Urology Drugs Sales Market Share by Type (2017-2028)

Figure 53. Asia Pacific Urology Drugs Revenue Market Share by Type (2017-2028)

Figure 54. Asia Pacific Urology Drugs Sales Market Share by Application (2017-2028)

Figure 55. Asia Pacific Urology Drugs Revenue Market Share by Application (2017-2028)

Figure 56. Asia Pacific Urology Drugs Sales Share by Region (2017-2028)

Figure 57. Asia Pacific Urology Drugs Revenue Share by Region (2017-2028)

Figure 58. China Urology Drugs Revenue (2017-2028) & (US$ Million)

Figure 59. Japan Urology Drugs Revenue (2017-2028) & (US$ Million)

Figure 60. South Korea Urology Drugs Revenue (2017-2028) & (US$ Million)

Figure 61. India Urology Drugs Revenue (2017-2028) & (US$ Million)

Figure 62. Australia Urology Drugs Revenue (2017-2028) & (US$ Million)

Figure 63. Taiwan Urology Drugs Revenue (2017-2028) & (US$ Million)

Figure 64. Indonesia Urology Drugs Revenue (2017-2028) & (US$ Million)

Figure 65. Thailand Urology Drugs Revenue (2017-2028) & (US$ Million)

Figure 66. Malaysia Urology Drugs Revenue (2017-2028) & (US$ Million)

Figure 67. Philippines Urology Drugs Revenue (2017-2028) & (US$ Million)

Figure 68. Latin America Urology Drugs Sales Market Share by Type (2017-2028)

Figure 69. Latin America Urology Drugs Revenue Market Share by Type (2017-2028)

Figure 70. Latin America Urology Drugs Sales Market Share by Application (2017-2028)

Figure 71. Latin America Urology Drugs Revenue Market Share by Application (2017-2028)

Figure 72. Latin America Urology Drugs Sales Share by Country (2017-2028)

Figure 73. Latin America Urology Drugs Revenue Share by Country (2017-2028)

Figure 74. Mexico Urology Drugs Revenue (2017-2028) & (US$ Million)

Figure 75. Brazil Urology Drugs Revenue (2017-2028) & (US$ Million)

Figure 76. Argentina Urology Drugs Revenue (2017-2028) & (US$ Million)

Figure 77. Middle East and Africa Urology Drugs Sales Market Share by Type (2017-2028)

Figure 78. Middle East and Africa Urology Drugs Revenue Market Share by Type (2017-2028)

Figure 79. Middle East and Africa Urology Drugs Sales Market Share by Application (2017-2028)

Figure 80. Middle East and Africa Urology Drugs Revenue Market Share by Application (2017-2028)

Figure 81. Middle East and Africa Urology Drugs Sales Share by Country (2017-2028)

Figure 82. Middle East and Africa Urology Drugs Revenue Share by Country (2017-2028)

Figure 83. Turkey Urology Drugs Revenue (2017-2028) & (US$ Million)

Figure 84. Saudi Arabia Urology Drugs Revenue (2017-2028) & (US$ Million)

Figure 85. U.A.E Urology Drugs Revenue (2017-2028) & (US$ Million)

Figure 86. Urology Drugs Value Chain

Figure 87. Urology Drugs Production Process

Figure 88. Channels of Distribution

Figure 89. Distributors Profiles

Figure 90. Bottom-up and Top-down Approaches for This Report

Figure 91. Data Triangulation

Figure 92. Key Executives Interviewed

REPORTS VIEWED RECENTLY

Global Urology Drugs Market Insights and Forecast to 2028

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Urology Drugs Market Insights and Forecast to 2028

Published Date: January 2022

Report Code: QYRE-Auto-6T8081

Global Urology Drugs Market Insights and Forecast to 2028

Code: QYRE-Auto-6T8081

Report

January 2022

72 Pages

QYResearch

Region: China, Global,

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

REPORTS VIEWED RECENTLY

SELECT A FORMAT

Single User

Electronic (PDF)

$4900

Multi User

Electronic (PDF)

$7350

Enterprise User

Electronic (PDF)

$9800

HAVE A QUERY?

OUR CUSTOMER

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-12T7632

Fri May 13 00:00:00 UTC 2022

Add to Cart

120 Pages

Type: Report

Code: QYRE-Auto-0T7466

Fri May 13 00:00:00 UTC 2022

Add to Cart

120 Pages

Type: Report

Code: QYRE-Auto-36U7490

Fri May 13 00:00:00 UTC 2022

Add to Cart

120 Pages

Type: Report

Code: QYRE-Auto-14C7602

Fri May 13 00:00:00 UTC 2022

Add to Cart

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions